flutamide and metallothionein

flutamide has been researched along with metallothionein in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chun, KJ; Kim, KW; Kim, SY; Lee, CH; Lee, SM	1

Other Studies

1 other study(ies) available for flutamide and metallothionein

Article	Year
Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats. International journal of molecular sciences, 2021, May-18, Volume: 22, Issue:10 Topics: Androgen Receptor Antagonists; Animals; Anti-Bacterial Agents; Auditory Threshold; Cochlea; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Evoked Potentials, Auditory, Brain Stem; Flutamide; Gene Expression; Hearing Loss, Sensorineural; Kanamycin; Low Density Lipoprotein Receptor-Related Protein-2; Male; Metallothionein; Protective Agents; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha	2021

Article

Year

Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats.

International journal of molecular sciences, 2021, May-18, Volume: 22, Issue:10

Topics: Androgen Receptor Antagonists; Animals; Anti-Bacterial Agents; Auditory Threshold; Cochlea; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Evoked Potentials, Auditory, Brain Stem; Flutamide; Gene Expression; Hearing Loss, Sensorineural; Kanamycin; Low Density Lipoprotein Receptor-Related Protein-2; Male; Metallothionein; Protective Agents; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha

2021